Peptide-Based Therapies Show Promise in Wound Care Pipeline
Several peptide-loaded hydrogels are already in Phase 3 clinical trials for chronic and acute wound care, signaling an accelerating transition from bench to pharmacy shelf.
#Peptide-Therapeutics
2 stories
Peptide Therapeutics Market to Reach $70.2 Billion by 2031 at 7.16% CAGR
Mordor Intelligence reports the global peptide therapeutics market valued at $49.68B in 2026, projected to reach $70.2B by 2031 driven by cancer, metabolic disorders, and oral delivery advances.